Mexico Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis

Mexico Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis


$ 3999

The Mexico Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $50 Mn in 2022, and is predicted to grow at (CAGR) of 8.05% from 2023 to 2030, to US $92 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic leukemia cases, rising demand for therapeutics, increased government funding initiatives, and other factors. The industry is primarily dominated by players such as Liomont, Novartis, Sanofi, Pfizer Inc, among other players.

ID: IN10MXPH423 CATEGORY: Pharmaceuticals GEOGRAPHY: Mexico AUTHOR: Riddhi Solanki

Buy Now

Mexico Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis

The Mexico Acute Lymphocytic Leukemia (ALL) Therapeutics Market is at around US $50 Mn in 2022 and is projected to reach US $92 Mn in 2030, exhibiting a CAGR of 8.05% during the forecast period.

Acute lymphocytic leukemia (ALL) is a blood and bone marrow cancer that impacts lymphocytes, white blood cells essential for the immune system's functioning. This condition involves the rapid development of immature lymphocytes called lymphoblasts due to a mutation, leading to an accumulation of undifferentiated lymphocytes. Common symptoms include recurring infections, respiratory issues, weight loss, bone pain, and fever, among others. Managing ALL involves a comprehensive and prolonged treatment strategy that comprises chemotherapy, targeted therapies, CAR-T cell immunotherapy, and, in rare cases, stem cell transplantation. These advancements in treatment significantly enhance the possibility of a cure, often achieving notable success rates of approximately 80% in children and adults.

Mexico is a country located in the southern part of North America, ordering the USA. In Mexico, evidence suggests that the overall incidence of ALL is around 44.05%. With improved healthcare infrastructure that allows rapid diagnosis coupled with environmental factors, genetic predisposition, and modifiable risk factors, the prevalence is anticipated to increase. The market is therefore driven by major factors like the surge in the incidence of ALL cases, rising demand for therapeutics, and increased government funding in the therapeutics industry. However, conditions such as an unstable regulatory environment, affordability, and accessibility of therapeutics, among others, hinder the growth and potential of the market.

Mexico Acute Lymphocytic Leukemia (ALL) Therapeutics Market Report 2022 to 2030

Market Dynamics

Market Growth Drivers

Increased incidence of ALL: The Instituto Mexicano del Seguro Social (IMSS) estimates that the overall incidence of ALL in Mexico is 44.05%. According to epidemiological studies using population-based registries, the incidence rate of ALL is highest in Mexican children. These statistics indicate the rising burden of ALL, which drives the industry.

Rising demand for therapeutics: The increasing prevalence of ALL in the city and the need for innovative and cost-effective therapeutic treatments are drivers of market growth.

Increased government funding: Mexico runs several initiatives to fund the healthcare needs of the population. The healthcare sector in Mexico has received considerable financing from the government and private players, which is anticipated to propel the growth of the ALL-therapeutics market in the country.

Technological Innovation: Innovation in the therapeutic market is significantly influenced by the expanding leadership of biotechnology in the Mexican health sector, including the use of genetic engineering and biopharmaceuticals. This technical innovation has the potential to contribute to the growth of ALL therapeutics market.

Market Restraints

Access and affordability: Advanced treatments such as CAR-T cell therapy and newer targeted medications are excessively costly for numerous Mexican patients, restricting their access to state-of-the-art treatment alternatives. In addition, the inequity in access of therapeutics acts as a hindrance.

Regulatory landscape: Mexico has a complex regulatory process that can delay its availability to end users.

Healthcare Infrastructure: Inadequate healthcare infrastructure in specific regions, shortages of qualified healthcare professionals, and limited availability of facilities that can provide advanced treatment produce inefficiencies in the system and may impede the availability and use of advanced ALL therapies across Mexico.

Notable updates

February 2023, COFEPRIS, Mexico's regulatory agency, granted approval for the use of Blinatumomab (Blincyto) CAR-T cell therapy in paediatric patients with relapsed or refractory B-cell ALL.

November 2022, COFEPRIS granted approval to Inotuzumab ozogamicin (IOGA), an antibody-drug conjugate for treating relapsed or refractory B-cell ALL in children and adolescents.

Healthcare Policies and Regulatory Landscape

In Mexico, various significant authorities and agencies manage the healthcare policies and regulatory framework. The primary entity overseeing healthcare products, including pharmaceuticals, is the Federal Commission for Protection against Sanitary Risk (COFEPRIS). COFEPRIS holds responsibility for regulating, supervising, and authorizing health-related products, encompassing all therapeutics.

Besides COFEPRIS, the Mexican healthcare system involves a blend of public and private healthcare provisions. The public healthcare sector is managed by the Ministry of Health (Secretaría de Salud), entrusted with the responsibility of delivering healthcare services to the population.

Compliance with COFEPRIS requirements is a prerequisite for obtaining a license in Mexico. Before commercializing therapeutics, companies are required to get registration and marketing licenses from COFEPRIS. Technical and scientific data proving the product's efficacy, safety, and quality must be submitted as part of the registration process.

Mexico has a strong regulatory framework and a resilient healthcare system, creating an advantageous setting for businesses to function effectively. Additionally, its geographical proximity to the United States provides favourable market access, allowing companies to reach and engage with North American markets.

Competitive Landscape

Key Players

  • Laboratorios Pisa
  • Grupo Biotoscana
  • Liomont
  • Sanofi
  • Pfizer Inc.
  • AstraZeneca PLC
  • Roche
  • Johnson and Johnson
  • Vitalmex
  • Merck Co & Inc

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Mexico Acute Lymphocytic Leukemia (ALL) Therapeutics Market Segmentation

By Type

  • Paediatrics
  • Adults

By Drug

  • Hyper CVAD regimen
  • Linker Regimen
  • Nucleoside Metabolic Inhibitors
  • Targeted drugs and Immunotherapy
  • CALGB 811 Regimen

By Cell

  • B Cell ALL
  • T Cell ALL
  • Philadelphia Chromosome

By Therapy

  • Chemotherapy
  • Targeted therapy
  • Radiation therapy
  • Stem Cell Transplantation

By Distribution channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 13 February 2024
Updated by: Keta Vora

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up